DCGI: In case of adverse reaction, don't use Digene gel
Wednesday, 6 September 2023
The Drug Controller General of India (DCGI) has advised doctors and healthcare professionals to educate their patients to discontinue the use of Digene gel - a commonly prescribed anti-acidity formulation - in case there is an adverse drug reaction (ADR).
The Drug Controller General of India (DCGI) has advised doctors and healthcare professionals to educate their patients to discontinue the use of Digene gel - a commonly prescribed anti-acidity formulation - in case there is an adverse drug reaction (ADR).
|
||||
💡 newsR Knowledge: Other News MentionsYou Might Like |